An overview of Gilead Sciences Inc.’s (GILD) institutional holdings
The price of Gilead Sciences Inc. (NASDAQ:GILD) shares last traded on Wall Street rose 2.01% to $74.74. Based on available information, 32 analysts follow Gilead Sciences Inc. (NASDAQ:GILD). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $116.00 and a low of […]
Gilead Sciences Inc. (NASDAQ:GILD) Risks You Should Know Before Investing
In yesterday’s Wall Street session, Gilead Sciences Inc. (NASDAQ:GILD) shares traded at $75.55, up 0.03% from the previous session. 31 analysts cover Gilead Sciences Inc. (NASDAQ:GILD), according to research data. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $116.00 and a […]
There is little time left for Gilead Sciences Inc. (GILD) to reach its 1-year target estimate. How soon will it surpass it?
Gilead Sciences Inc. (NASDAQ:GILD) shares traded -2.18% lower at $75.67 on Wall Street last session. In accordance with the data, 29 analysts cover Gilead Sciences Inc. (NASDAQ:GILD). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $116.00 and a low of $71.00, […]
A secret that hides Gilead Sciences Inc.’s strength (NASDAQ:GILD)
Stocks of Gilead Sciences Inc. (NASDAQ:GILD) traded higher last session on Wall Street, up 2.79% to $76.00. According to the data, Gilead Sciences Inc. (NASDAQ:GILD) has 29 analysts covering its stock. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $116.00 and […]
A Stock With Stellar Fundamentals? Gilead Sciences Inc. (NASDAQ:GILD): Is It Right For You?
Stocks of Gilead Sciences Inc. (NASDAQ:GILD) traded higher last session on Wall Street, down -1.22% to $74.24. According to the data, Gilead Sciences Inc. (NASDAQ:GILD) has 30 analysts covering its stock. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $116.00 and […]
Do you still think Gilead Sciences Inc. (NASDAQ:GILD) is worth a look?
Stocks of Gilead Sciences Inc. (NASDAQ:GILD) traded higher last session on Wall Street, down -0.70% to $77.66. According to the data, Gilead Sciences Inc. (NASDAQ:GILD) has 30 analysts covering its stock. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $116.00 and […]
How should investors evaluate Gilead Sciences Inc. (NASDAQ:GILD)?
Stocks of Gilead Sciences Inc. (NASDAQ:GILD) traded higher last session on Wall Street, down -0.81% to $75.88. According to the data, Gilead Sciences Inc. (NASDAQ:GILD) has 30 analysts covering its stock. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $116.00 and […]
Does Gilead Sciences Inc. (NASDAQ:GILD) warrant a purchase right now? What to Consider Before Making a Decision
Gilead Sciences Inc. (NASDAQ:GILD) shares traded -2.06% lower at $78.00 on Wall Street last session. In accordance with the data, 30 analysts cover Gilead Sciences Inc. (NASDAQ:GILD). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $116.00 and a low of $80.00, […]
Gilead Sciences Inc. (GILD) – it’s time to buy. Check out key Indicators
In yesterday’s Wall Street session, Gilead Sciences Inc. (NASDAQ:GILD) shares traded at $78.68, up 4.17% from the previous session. As of this writing, 31 analysts cover Gilead Sciences Inc. (NASDAQ:GILD). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $115.00 and a […]
Do investors have a safe investment in Gilead Sciences Inc. (NASDAQ:GILD)?
In yesterday’s Wall Street session, Gilead Sciences Inc. (NASDAQ:GILD) shares traded at $78.96, up 0.95% from the previous session. 30 analysts cover Gilead Sciences Inc. (NASDAQ:GILD), according to research data. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $115.00 and a […]
